Findings

What do systematic reviews say?

2 questions · 2 findings · 2 reviews · Musculoskeletal

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 0 · 0%Moderate 1 · 50%High 0 · 0%

Serious adverse events · postmenopausal women at lower risk of fractures1

Intermittent/cyclic etidronate 400 mg/day showed no clear difference in serious adverse events compared with placebo (moderate certainty).

1 finding from 1 review

Serious adverse events · postmenopausal women at lower risk of fractures1

It is very uncertain whether risedronate 5 mg/day changes serious adverse events compared with placebo (very low certainty).

1 finding from 1 review